TOKYO, Nov 20, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that the amyotrophic lateral sclerosis (ALS) treatment“Rozebalamin® for Injection25 mg” (mecobalamin) has been launched in Japan ...
Rozebalamin(R) For Injection 25 Mg (Mecobalamin) Approved In Japan For Amyotrophic Lateral Sclerosis
Eisai Co., Ltd. announced today that it has obtained manufacturing and marketing authorization approval for amyotrophic lateral sclerosis (ALS) treatment“Rozebalamin® for Injection 25 mg” (mecobalamin ...
April 25, 2013-Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that it has decided to establish a new parenteral facility (below, "New Plant") on a lot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results